Loading data for MAIA — first visit, this takes a few seconds.
MAIA Biotechnology Inc. (MAIA)
NYSE American: MAIA
· Real-Time Price · USD
1.39
-0.02 (-1.42%)
At close: Aug 27, 2026, 8:00 PM
1.38
+0.00%
After-hours: 4:15 PM
The price, the headline numbers and the latest news, in one place.
MAIA Biotechnology Inc. (MAIA) Stock Price, Analysis & Data
-1.42% (1D)
No data available
| Bid | 1.38 |
| Market Cap | 83.95M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -26.85M |
| 0.25 | |
| -0.63 | |
| n/a | |
| 1.24 | |
| P/B (ttm) | 4.06 |
| P/S (ttm) | n/a |
| Earnings Date | Aug 8, 2025 |
| Ask | 1.41 |
| Volume | 556,609 |
| Avg. Volume (20D) | 663,876 |
| Open | 1.41 |
| Previous Close | 1.41 |
| Day's Range | 1.39 - 1.47 |
| 52-Week Range | 0.87 - 3.19 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MAIA
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois....
Industry Biotechnology
Sector Healthcare
IPO Date Jul 28, 2022
Employees 13
Stock Exchange NYSE American
Ticker Symbol MAIA
Website https://maiabiotech.com
Financial Performance
In 2025, MAIA Biotechnology's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -22.4M, a decrease of -3.69%.
Financial StatementsEarnings Surprise
MAIA Biotechnology has released their quarterly earnings on Aug 10, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.13 misses estimates by -0.02, with 23.53% YoY growth.
MAIA Biotechnology Inc. is scheduled to release its earnings on Aug 8, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
